Immobilization of homogeneous monomeric, oligomeric and fibrillar Aβ species for reliable SPR measurements

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Frenzel, Daniel ^a   Glück, Julian M ^a   Brener, Oleksandr ^a,b   Oesterhelt, Filipp ^b   Nagel Steger, Luitgard ^a,b   Willbold, Dieter ^a,b  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; LIGAND; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; BIOPOLYMER;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANALYTIC METHOD; ARTICLE; CARBOXY TERMINAL SEQUENCE; DENSITY GRADIENT CENTRIFUGATION; EXPERIMENTAL STUDY; FIBER; HUMAN; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN IMMOBILIZATION; PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SURFACE PLASMON RESONANCE; CHEMISTRY; GEL CHROMATOGRAPHY; KINETICS; METABOLISM; PROCEDURES; PROTEIN CONFORMATION;

AMYLOID BETA-PEPTIDES; BIOPOLYMERS; CHROMATOGRAPHY, GEL; KINETICS; PROTEIN CONFORMATION; SURFACE PLASMON RESONANCE;

EID: 84897106012     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089490     Document Type: Article

References (24)

1. Gulland A (2012) Number of people with dementia will reach 65.7 million by 2030, says report. Bmj 344: e2604.
2. Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nature medicine 10 Suppl: S10-17. (Pubitemid 38901862)
3. Tanzi RE, Bertram L (2005) Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120: 545-555. (Pubitemid 40269768)
4. Schmidt ML, DiDario AG, Otvos L Jr, Hoshi N, Kant JA, et al. (1994) Plaque-associated neuronal proteins: a recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain. Experimental neurology 130: 311-322.
5. Milligan CE (2000) Caspase cleavage of APP results in a cytotoxic proteolytic peptide. Nature medicine 6: 385-386.
6. Xia N, Liu L, Harrington MG, Wang J, Zhou F (2010) Regenerable and simultaneous surface plasmon resonance detection of abeta(1-40) and abeta(1-42) peptides in cerebrospinal fluids with signal amplification by streptavidin conjugated to an N-terminus-specific antibody. Analytical chemistry 82: 10151-10157.
7. Wang-Dietrich L, Funke SA, Kühbach K, Wang K, Besmehn A, et al. (2013) The amyloid-beta oligomer count in cerebrospinal fluid is a biomarker for Alzheimer's disease. Journal of Alzheimer's disease: JAD 34: 985-994.
8. Stravalaci M, Bastone A, Beeg M, Cagnotto A, Colombo L, et al. (2012) Specific recognition of biologically active amyloid-beta oligomers by a new surface plasmon resonance-based immunoassay and an in vivo assay in Caenorhabditis elegans. The Journal of biological chemistry 287: 27796-27805.
9. Bruggink KA, Jongbloed W, Biemans EA, Veerhuis R, Claassen JA, et al. (2013) Amyloid-beta oligomer detection by ELISA in cerebrospinal fluid and brain tissue. Analytical biochemistry 433: 112-120.
10. Esparza TJ, Zhao H, Cirrito JR, Cairns NJ, Bateman RJ, et al. (2013) Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls. Annals of neurology 73: 104-119.
11. Finder VH, Glockshuber R (2007) Amyloid-beta aggregation. Neuro-degenerative diseases 4: 13-27.
12. Stenberg E, Persson B, Roos H, Urbaniczky C (1991) Quantitative- Determination of Surface Concentration of Protein with Surface-Plasmon Resonance Using Radiolabeled Proteins. J Colloid Interf Sci 143: 513-526.
13. Johansson AS, Berglind-Dehlin F, Karlsson G, Edwards K, Gellerfors P, et al. (2006) Physiochemical characterization of the Alzheimer's disease-related peptides A beta 1-42Arctic and A beta 1-42wt. The FEBS journal 273: 2618-2630.
14. Wood SJ, Maleeff B, Hart T, Wetzel R (1996) Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta. Journal of molecular biology 256: 870-877. (Pubitemid 26108825)
15. Nagel-Steger L, Demeler B, Meyer-Zaika W, Hochdorffer K, Schrader T, et al. (2010) Modulation of aggregate size- and shape-distributions of the amyloid-beta peptide by a designed beta-sheet breaker. European biophysics journal: EBJ 39: 415-422.
16. Karlsson R, Katsamba PS, Nordin H, Pol E, Myszka DG (2006) Analyzing a kinetic titration series using affinity biosensors. Analytical biochemistry 349: 136-147. (Pubitemid 43129567)
17. Amijee H, Bate C, Williams A, Virdee J, Jeggo R, et al. (2012) The N-methylated peptide SEN304 powerfully inhibits Abeta(1-42) toxicity by perturbing oligomer formation. Biochemistry 51: 8338-8352.
18. Green NM (1963) Avidin. 1. The Use of (14-C)Biotin for Kinetic Studies and for Assay. The Biochemical journal 89: 585-591.
19. Glück JM, Koenig BW, Willbold D (2011) Nanodiscs allow the use of integral membrane proteins as analytes in surface plasmon resonance studies. Analytical biochemistry 408: 46-52.
20. Dornieden S, Müller-Schiffmann A, Sticht H, Jiang N, Cinar Y, et al. (2013) Characterization of a single-chain variable fragment recognizing a linear epitope of abeta: a biotechnical tool for studies on Alzheimer's disease? PloS one 8: e59820.
21. Müller-Schiffmann A, Marz-Berberich J, Andreyeva A, Ronicke R, Bartnik D, et al. (2010) Combining independent drug classes into superior, synergistically acting hybrid molecules. Angewandte Chemie 49: 8743-8746.
22. Ford T, Graham J, Rickwood D (1994) Iodixanol: a nonionic iso-osmotic centrifugation medium for the formation of self-generated gradients. Analytical biochemistry 220: 360-366.
23. Stine WB Jr, Snyder SW, Ladror US, Wade WS, Miller MF, et al. (1996) The nanometer-scale structure of amyloid-beta visualized by atomic force microscopy. Journal of protein chemistry 15: 193-203. (Pubitemid 3040251)
24. Cannon MJ, Williams AD, Wetzel R, Myszka DG (2004) Kinetic analysis of beta-amyloid fibril elongation. Analytical biochemistry 328: 67-75. (Pubitemid 38479619)